With this latest approval, children aged six months to four years who have completed their primary series with three doses of the companies’ original vaccine will be able to receive a 3µg booster dose of the bivalent vaccine after at least two months.
The vaccine is already authorised as the third dose of the three-dose primary series in this age group, but a booster dose is not authorised for these children at this time.